Back
AIA Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
58
AAIGF
AIA Group
Last Price:
8.70
Seasonality Move:
1.55%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
42.23
Seasonality Move:
12.29%
Buy
58
AIA Group (AAIGF)
is a Buy
Is AIA Group a Buy, Sell or Hold?
- The current AIA Group [AAIGF] share price is $8.23. The Score for AAIGF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- AAIGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $42.61. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $42.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
AAIGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 67.9 | Buy |
| Chaikin Money Flow: | 50688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.25 - 8.03) | Buy |
| Bollinger Bands (100): | (6.9 - 8.3) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.23 | Sell |
| Relative Strength Index (14 RSI): | 45.9 | Sell |
| Chaikin Money Flow: | 672942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.5 - 44.36) | Sell |
| Bollinger Bands (100): | (43.26 - 49.38) | Sell |
AAIGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.09 | Buy |
| 20-day SMA: | 7.43 | Buy |
| 50-day SMA: | 7.18 | Buy |
| 200-day SMA: | 8.15 | Buy |
| 8-day EMA: | 8.05 | Buy |
| 20-day EMA: | 7.63 | Buy |
| 50-day EMA: | 7.41 | Buy |
| 200-day EMA: | 8.14 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.41 | Buy |
| 20-day SMA: | 42.68 | Sell |
| 50-day SMA: | 45.44 | Sell |
| 200-day SMA: | 42.06 | Buy |
| 8-day EMA: | 41.75 | Buy |
| 20-day EMA: | 42.77 | Sell |
| 50-day EMA: | 44.51 | Sell |
| 200-day EMA: | 44.25 | Sell |
AIA Group Earnings Growth & AAIGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
AIA Group Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||